Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2017

01-08-2017 | Original Article

Venous thromboembolism prophylaxis risk assessment in a general surgery cohort: a closed-loop audit

Authors: D. M. McGoldrick, H. P. Redmond

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2017

Login to get access

Abstract

Background and aims

Venous thromboembolism (VTE) is a potential source of morbidity and mortality in surgical in-patients. A number of guidelines exist that advise on prophylactic measures. We aimed to assess VTE prophylaxis prescribing practices and compliance with a kardex-based risk assessment tool in a general surgery population.

Methods

Data on general surgery in-patients were collected on two separate wards on two separate days. Drug kardexes were assessed for VTE prophylaxis measures and use of the risk assessment tool. NICE and SIGN guidelines were adopted as a gold standard. The audit results and information on the risk assessment tool were presented as an educational intervention at two separate departmental teaching sessions. A re-audit was completed after 3 months.

Results

In Audit A, 74 patients were assessed. 70% were emergency admissions. The risk assessment tool was completed in 2.7%. 75 and 97% of patients were correctly prescribed anti-embolic stockings (AES) and low-molecular weight heparin (LMWH), respectively. 30 patients were included in Audit B, 56% of whom were emergency admissions. 66% had a risk assessment performed, a statistically significant improvement (p < 0.0001). Rates of LMWH prescribing were similar (96%), but AES prescribing was lower (36%).

Conclusion

Rates of LMWH prescribing are high in this general surgical population, although AES prescribing rates vary. Use of the VTE risk assessment tool increased following the initial audit and intervention.
Literature
1.
go back to reference The House of Commons Health Committee (2005) The prevention of venous thromboembolism in hospitalised patients. The Stationery Office Limited, London The House of Commons Health Committee (2005) The prevention of venous thromboembolism in hospitalised patients. The Stationery Office Limited, London
2.
go back to reference Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):338s–400sCrossRefPubMed Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):338s–400sCrossRefPubMed
7.
go back to reference Cohen AT, Tapson VF, Bergmann JF et al (2008) ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2(371):387–394CrossRef Cohen AT, Tapson VF, Bergmann JF et al (2008) ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2(371):387–394CrossRef
8.
go back to reference Murphy D, O’Connell O, Liston R et al (2012) Venous thromboembolism risk and prophylaxis in the acute hospital care setting: the Irish results of the ENDORSE study. Ir Med J 105(5):140–143PubMed Murphy D, O’Connell O, Liston R et al (2012) Venous thromboembolism risk and prophylaxis in the acute hospital care setting: the Irish results of the ENDORSE study. Ir Med J 105(5):140–143PubMed
Metadata
Title
Venous thromboembolism prophylaxis risk assessment in a general surgery cohort: a closed-loop audit
Authors
D. M. McGoldrick
H. P. Redmond
Publication date
01-08-2017
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2017
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-016-1529-0

Other articles of this Issue 3/2017

Irish Journal of Medical Science (1971 -) 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.